Detalles de la búsqueda
1.
Evolutionary trajectories of small cell lung cancer under therapy.
Nature
; 627(8005): 880-889, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38480884
2.
Diagnostic yield, indications, and outcomes of cranial imaging in AML patients admitted for intensive induction or consolidation chemotherapy: a single-center experience.
Ann Hematol
; 102(5): 1045-1052, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36947211
3.
Early-onset venous thromboembolisms in newly diagnosed non-promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy.
Eur J Haematol
; 110(4): 426-434, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36573351
4.
Evolution of treatment patterns and survival outcomes in patients with advanced non-small cell lung cancer treated at Frankfurt University Hospital in 2012-2018.
BMC Pulm Med
; 23(1): 16, 2023 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36639770
5.
Cancer, cancer treatment and aneurysmatic ascending aorta growth within a retrospective single center study.
Vasa
; 52(1): 38-45, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36373268
6.
Relapse surveillance of acute myeloid leukemia patients in first remission after consolidation chemotherapy: diagnostic value of regular bone marrow aspirations.
Ann Hematol
; 101(8): 1703-1710, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35595925
7.
Intracranial hemorrhage in newly diagnosed non-promyelocytic acute myeloid leukemia patients admitted for intensive induction chemotherapy.
Eur J Haematol
; 108(2): 125-132, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34714547
8.
Returning to work in lung cancer survivors-a multi-center cross-sectional study in Germany.
Support Care Cancer
; 29(7): 3753-3765, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33211206
9.
Clinical and genetic characterization of de novo double-hit B cell precursor leukemia/lymphoma.
Ann Hematol
; 98(3): 647-656, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30613837
10.
Concepts of lines of therapy in cancer treatment: findings from an expert interview-based study.
BMC Res Notes
; 17(1): 137, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38750530
11.
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany.
Eur J Cancer
; 201: 113911, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38377774
12.
Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting.
J Cancer Res Clin Oncol
; 149(11): 9243-9252, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37198447
13.
Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer.
Front Oncol
; 13: 1273478, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37810988
14.
Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis.
Ther Adv Med Oncol
; 14: 17588359221097191, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35677321
15.
Colonization with multidrug-resistant organisms impairs survival in patients with hepatocellular carcinoma.
J Cancer Res Clin Oncol
; 148(6): 1465-1472, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34283288
16.
Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia.
Leukemia
; 36(10): 2396-2407, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35999260
17.
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations.
J Thorac Oncol
; 16(11): 1952-1958, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34245914
18.
Colonization with multi-drug-resistant organisms negatively impacts survival in patients with non-small cell lung cancer.
PLoS One
; 15(11): e0242544, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33237921
19.
Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers.
Lung Cancer (Auckl)
; 10: 67-80, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31308774
20.
Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer.
J Cancer Res Clin Oncol
; 144(12): 2457-2463, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30244389